Skip to Main Content

Author Details

John S Albin
Massachusetts General Hospital
2008
16
11
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36696625Mpox in Young Woman with No Epidemiologic Risk Factors, Massachusetts, USA.Emerg Infect Dis2023
36036367Development and implementation of a clinical decision support system tool for the evaluation of suspected monkeypox infection.J Am Med Inform Assoc2022
34159495Preventing Infectious Complications of Immunomodulation in COVID-19 in Foreign-Born Patients.J Immigr Minor Health2021
33564833Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator).Clin Infect Dis2021
32431323Efficient flow synthesis of human antimicrobial peptides.Aust J Chem2020
29677220HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.PLoS Pathog2018
26628363The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches.Cell Rep2015
24503066Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.Virology2014
25142588APOBEC3F determinants of HIV-1 Vif sensitivity.J Virol2014
23318957Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.J Mol Biol2013
23685212Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.Structure2013
20096141Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.Expert Rev Mol Med2010
20686027Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.J Virol2010
20971849A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.J Biol Chem2010
20308164Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.Nucleic Acids Res2010
18501607Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G.Curr Biol2008
  • 1 - 16 of 16

Recommended Authors

University of California los angeles
Career Start Year 2014
Number of shared co-authors 3
University of Toronto
Career Start Year 2011
Number of shared co-authors 3
University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 1
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2010
Number of shared co-authors 6
University of Utah
Career Start Year 2009
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 2009
Number of shared co-authors 2
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 3
MRC-University of Glasgow Centre for Virus Research, University of Glasgow
Career Start Year 2008
Number of shared co-authors 1
University of California San Diego
Career Start Year 2007
Number of shared co-authors 3
Drexel University College of Medicine
Career Start Year 2007
Number of shared co-authors 0
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2005
Number of shared co-authors 1
Institute for Experimental Pathology, University of Iceland
Career Start Year 2005
Number of shared co-authors 7
Graduate School of Medicine, Kyoto University
Career Start Year 2004
Number of shared co-authors 3
University of Saskatchewan, College of Medicine
Career Start Year 2003
Number of shared co-authors 4
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 2
Paul-Ehrlich-Institut
Career Start Year 1998
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 4
University College London
Career Start Year 1995
Number of shared co-authors 1
The Rockefeller University
Career Start Year 1995
Number of shared co-authors 1
Inc., Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 2
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 3
Altius Institute for Biomedical Sciences
Career Start Year 1990
Number of shared co-authors 0
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 7
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 2
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 0
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 1972
Number of shared co-authors 1
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 1

Collaborators

University of Texas Health San Antonio
Co-authored papers 11
University of Minnesota
Co-authored papers 4
Frederick National Laboratory for Cancer Research
Co-authored papers 3
Massachusetts General Hospital
Co-authored papers 3
Graduate School of Medicine, Kyoto University
Co-authored papers 3
Co-authored papers 2
Co-authored papers 2
University of Minnesota
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
Massey University
Co-authored papers 2
University of Minnesota
Co-authored papers 1
University of Massachusetts Chan Medical School
Co-authored papers 1
University of California
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Gladstone Institutes
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Mass General Brigham Clinical Informatics
Co-authored papers 1
Minnesota Supercomputing Institute, University of Minnesota
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center
Co-authored papers 1
University of Massachusetts Medical School
Co-authored papers 1
Co-authored papers 1
Massachusetts General Hospital
Co-authored papers 1
University of Massachusetts Chan Medical School
Co-authored papers 1
Department of Cancer Research Institute, University of South Australia
Co-authored papers 1